Navi was honoured to be mentioned in the House Of Representatives at Parliament House today by the Federal Minister for Industry, Science and Technology, Hon. Karen Andrews, who gave a speech outlining some of the recent significant achievements made by Australian medical companies.
In her speech, Navi was highlighted and commended for its recent successes in the development and commercialisation of the Neonav Catheter Tip Location System; a medical device that aims to helps improve catheter placement in critically-ill newborns and pediatric patients.
Navi CFO Wei Sue noted that the Navi team were pleased to be included in the Minister’s speech among incredibly successfully medtech companies like ResMed and Cochlear;
“Like many, COVID-19 has been a challenging year for our company. But, our team has shown incredible resilience continues to make significant strides in the commercialisation of the Neonav device, including as the Minister mentioned, expanding our clinical research activities as well as setting up a US subsidiary in preparation for US market entry in the future.”
“It is an honour to be mentioned among some of Australia’s most successful medtech organisations. The incredible support of the Federal Government through the Accelerating Commercialisation Grant has provided us with critical resources in this commercialisation journey, and ultimately will help us achieve our goal of providing children everywhere with brighter, healthier futures.”
Below is a partial transcript from the Minister’s speech, spoken in the House Of Representatives on 22 February 2021:
“Many of us here would be very familiar with the Cochlear story and the work they have been doing with their hearing technology solutions. I've already mentioned ResMed and what they did with ventilators. But there are so many fledgling companies that are producing medical products right across Australia. We as Australians should be so proud of them and the work they are doing. They are great examples. One business, a Melbourne based business, is Navi Medical Technologies. Last year this government backed them with a grant of $400,000 to help them commercialise their new catheter technology for seriously ill babies. Even during COVID, faced with enormous challenges, they expanded their business. They employed an extra six people. They set up an Aussie-owned office in the United States, and they significantly progressed their clinical research.”